FDA should halt Lilly bloodthinner review: U.S. group (Reuters)
Reuters - * Group, researcher urge study of lower prasugrel dose
This entry was posted
on Wednesday, June 3rd, 2009 at 4:42 pm and is filed under Health.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.